Phase II Trial of Intraperitoneal Cisplatin with Intravenous Doxorubicin and Cyclophosphamide in Previously Untreated Patients with Advanced Ovarian Cancer-Long-Term Follow-Up

Author： Morgan R.J.   Braly P.   Cecchi G.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Parker P.   Stein A.   Cho J.   Smith E.   Coluzzi P.   Najera L.   Johnson D.   Womack E.   Doroshow J.H.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.75, Iss.3, 1999-12, pp. : 419-426

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of Combination Intraperitoneal Cisplatin and 5-Fluorouracil in Previously Treated Patients with Advanced Ovarian Cancer: Long-Term Follow-up

By Morgan R.J.   Braly P.   Leong L.   Shibata S.   Margolin K.   Somlo G.   McNamara M.   Longmate J.   Schinke S.   Raschko J.   Nagasawa S.   Kogut N.   Najera L.   Johnson D.   Doroshow J.H.  

Gynecologic Oncology, Vol. 77, Iss. 3, 2000-06 ,pp. : 433-438

Elsevier

Access to resources Recommend Favorite

High-Intensity Intravenous Cyclophosphamide and Cisplatin, Interim Surgical Debulking, and Intraperitoneal Cisplatin in Advanced Ovarian Carcinoma: A Pilot Trial with Ten-Year Follow-up

By Shapiro F.   Schneider J.   Markman M.   Reichman B.S.   Venkatraman E.   Barakat R.   Almadrones L.   Spriggs D.  

Gynecologic Oncology, Vol. 67, Iss. 1, 1997-10 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Intraperitoneal Cisplatin and Mitoxantrone in Patients with Persistent Ovarian Cancer

By Husain A.   Sabbatini P.   Spriggs D.   Fennelly D.   Aghajanian C.   Barakat R.   Curtin J.   Venkatraman E.   Hoskins W.   Markman M.  

Gynecologic Oncology, Vol. 73, Iss. 1, 1999-04 ,pp. : 96-101

Elsevier

Access to resources Recommend Favorite

A Phase I Study of Paclitaxel, Doxorubicin, and Cisplatin in Patients with Previously Untreated Epithelial Ovarian Cancer

By Naumann R.W.   Alvarez R.D.   Omura G.A.   Segars E.   Kilgore L.C.   Partridge E.E.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 450-453

Elsevier

Access to resources Recommend Favorite

Intraperitoneal versus Intravenous Cisplatin in Combination with Intravenous Cyclophosphamide and Epidoxorubicin in Optimally Cytoreduced Advanced Epithelial Ovarian Cancer: A Randomized Trial of the Gruppo Oncologico Nord-Ovest

By Gadducci A.   Carnino F.   Chiara S.   Brunetti I.   Tanganelli L.   Romanini A.   Bruzzone M.   Conte P.F.   GONO Collaborative Centers  

Gynecologic Oncology, Vol. 76, Iss. 2, 2000-02 ,pp. : 157-162

Elsevier

Access to resources Recommend Favorite